Showing results (31-40 of 296) with videos related to

Sort By:
Pageof 30
Cancer Letters|February 26, 1997
In vitro mutagenicity of the plasmacytomagenic agent pristane (2,6,10,14-tetramethylpentadecane)K Felix, M Potter, G W Bornkamm, et al.
International Journal of Cancer|March 15, 1977
Heterogeneity of Epstein-Barr virus originating from P3HR-1 cells. I. Studies on EBNA inductionK O Fresen, B Merkt, G W Bornkamm, et al.
Journal of the National Cancer Institute|June 1, 1986
Attachment of antinuclear antibodies to nasopharyngeal carcinoma or other cells during preparation of biopsy imprintsW Henle, G Henle, A P Lanier, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1979
Tumor initiators and promoters in the induction of Epstein-Barr virusH zur Hausen, G W Bornkamm, R Schmidt, et al.
Medical Microbiology and Immunology|January 1, 1983
Establishment of spontaneously outgrowing lymphoblastoid cell lines with Cyclosporin AM von Knebel Doeberitz, G W Bornkamm, H zur Hausen
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1984
No evidence for differences in the Epstein-Barr virus genome carried in Burkitt lymphoma cells and nonmalignant lymphoblastoid cells from the same patientsG W Bornkamm, M von Knebel-Doeberitz, G M Lenoir
Scandinavian Journal of Immunology|October 1, 1994
Differential role of protein kinase C in cytokine induced lymphocyte-endothelium interaction in vitroG Eissner, W Kölch, H Mischak, et al.
Pageof 30